| About-cancer/advanced-cancer |
18 |
1 |
94% |
0% |
0% |
| About-cancer/advanced-cancer/care-choices |
37 |
1 |
97% |
0% |
0% |
| About-cancer/advanced-cancer/caregivers |
5 |
1 |
80% |
0% |
0% |
| About-cancer/advanced-cancer/caregivers/planning |
97 |
1 |
98% |
0% |
0% |
| About-cancer/advanced-cancer/caregivers/self-care |
40 |
1 |
97% |
0% |
0% |
| About-cancer/advanced-cancer/feelings |
78 |
1 |
98% |
0% |
0% |
| About-cancer/advanced-cancer/planning |
63 |
1 |
98% |
0% |
0% |
| About-cancer/advanced-cancer/questions |
29 |
1 |
96% |
0% |
0% |
| About-cancer/advanced-cancer/research |
17 |
1 |
94% |
0% |
0% |
| About-cancer/advanced-cancer/talking |
85 |
2 |
97% |
0% |
0% |
| About-cancer/causes-prevention |
10 |
1 |
90% |
0% |
0% |
| About-cancer/causes-prevention/genetics |
24 |
1 |
95% |
0% |
0% |
| About-cancer/causes-prevention/genetics/directory |
9 |
1 |
88% |
0% |
0% |
| About-cancer/causes-prevention/patient-prevention-overview-pdq |
110 |
3 |
97% |
0% |
0% |
| About-cancer/causes-prevention/research |
66 |
1 |
98% |
0% |
0% |
| About-cancer/causes-prevention/risk |
12 |
1 |
91% |
0% |
0% |
| About-cancer/causes-prevention/risk/age |
7 |
1 |
85% |
0% |
0% |
| About-cancer/causes-prevention/risk/alcohol |
6 |
1 |
83% |
0% |
0% |
| About-cancer/causes-prevention/risk/chronic-inflammation |
5 |
1 |
80% |
0% |
0% |
| About-cancer/causes-prevention/risk/diet |
28 |
1 |
96% |
0% |
0% |
| About-cancer/causes-prevention/risk/hormones |
14 |
1 |
92% |
0% |
0% |
| About-cancer/causes-prevention/risk/immunosuppression |
6 |
1 |
83% |
0% |
0% |
| About-cancer/causes-prevention/risk/infectious-agents |
34 |
1 |
97% |
0% |
0% |
| About-cancer/causes-prevention/risk/myths |
29 |
1 |
96% |
0% |
0% |
| About-cancer/causes-prevention/risk/obesity |
9 |
1 |
88% |
0% |
0% |
| About-cancer/causes-prevention/risk/radiation |
11 |
1 |
90% |
0% |
0% |
| About-cancer/causes-prevention/risk/substances |
32 |
1 |
96% |
0% |
0% |
| About-cancer/causes-prevention/risk/sunlight |
14 |
1 |
92% |
0% |
0% |
| About-cancer/causes-prevention/risk/tobacco |
24 |
1 |
95% |
0% |
0% |
| About-cancer/coping |
12 |
1 |
91% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer |
17 |
1 |
94% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer/changes-for-family |
23 |
1 |
95% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer/spouse-or-partner |
28 |
1 |
96% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer/support-groups |
34 |
1 |
97% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer/talk-to-children |
40 |
1 |
97% |
0% |
0% |
| About-cancer/coping/adjusting-to-cancer/talk-with-doctors |
14 |
1 |
92% |
0% |
0% |
| About-cancer/coping/caregiver-support |
84 |
1 |
98% |
0% |
0% |
| About-cancer/coping/caregiver-support/caregiving-after-treatment |
38 |
1 |
97% |
0% |
0% |
| About-cancer/coping/caregiver-support/parents |
129 |
1 |
99% |
0% |
0% |
| About-cancer/coping/caregiver-support/teens |
125 |
1 |
99% |
0% |
0% |
| About-cancer/coping/day-to-day |
11 |
1 |
90% |
0% |
0% |
| About-cancer/coping/day-to-day/back-to-work |
20 |
1 |
95% |
0% |
0% |
| About-cancer/coping/day-to-day/daily-routine |
39 |
1 |
97% |
0% |
0% |
| About-cancer/coping/day-to-day/faith-and-spirituality |
24 |
1 |
95% |
0% |
0% |
| About-cancer/coping/feelings |
122 |
1 |
99% |
0% |
0% |
| About-cancer/coping/feelings/relaxation |
31 |
1 |
96% |
0% |
0% |
| About-cancer/coping/questions |
10 |
1 |
90% |
0% |
0% |
| About-cancer/coping/research |
41 |
1 |
97% |
0% |
0% |
| About-cancer/coping/self-image |
83 |
83 |
0% |
0% |
0% |
| About-cancer/coping/survivorship |
16 |
16 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/child-care |
71 |
71 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/family-issues |
24 |
24 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/follow-up-care |
80 |
80 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/late-effects |
111 |
111 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/new-normal |
34 |
34 |
0% |
0% |
0% |
| About-cancer/coping/survivorship/questions |
13 |
13 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging |
10 |
10 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/diagnosis |
38 |
38 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/prognosis |
41 |
41 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/questions |
16 |
16 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/research |
17 |
17 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/staging |
48 |
48 |
0% |
0% |
0% |
| About-cancer/diagnosis-staging/symptoms |
43 |
43 |
0% |
0% |
0% |
| About-cancer/managing-care |
11 |
1 |
90% |
0% |
0% |
| About-cancer/managing-care/advance-directives |
44 |
1 |
97% |
0% |
0% |
| About-cancer/managing-care/services |
103 |
1 |
99% |
0% |
0% |
| About-cancer/managing-care/services/providers |
28 |
1 |
96% |
0% |
0% |
| About-cancer/managing-care/services/support |
23 |
1 |
95% |
0% |
0% |
| About-cancer/managing-care/track-care-costs |
111 |
1 |
99% |
0% |
0% |
| About-cancer/managing-care/using-trusted-resources |
61 |
1 |
98% |
0% |
0% |
| About-cancer/screening |
8 |
1 |
87% |
0% |
0% |
| About-cancer/screening/patient-screening-overview-pdq |
129 |
1 |
99% |
0% |
0% |
| About-cancer/screening/research |
37 |
1 |
97% |
0% |
0% |
| About-cancer/screening/screening-tests |
39 |
1 |
97% |
0% |
0% |
| About-cancer/treatment |
14 |
1 |
92% |
0% |
0% |
| About-cancer/treatment/cam |
29 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/cam/hp |
51 |
51 |
0% |
0% |
0% |
| About-cancer/treatment/cam/patient |
54 |
1 |
98% |
0% |
0% |
| About-cancer/treatment/cam/patient/acupuncture-pdq |
146 |
1 |
99% |
0% |
0% |
| About-cancer/treatment/clinical-trials |
12 |
1 |
91% |
0% |
0% |
| About-cancer/treatment/clinical-trials/nci-supported |
26 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/clinical-trials/patient-safety |
9 |
1 |
88% |
0% |
0% |
| About-cancer/treatment/clinical-trials/patient-safety/childrens-assent |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/clinical-trials/patient-safety/ending-trials-early |
8 |
1 |
87% |
0% |
0% |
| About-cancer/treatment/clinical-trials/patient-safety/informed-consent |
17 |
1 |
94% |
0% |
0% |
| About-cancer/treatment/clinical-trials/patient-safety/scientific-review |
27 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/clinical-trials/paying |
15 |
1 |
93% |
0% |
0% |
| About-cancer/treatment/clinical-trials/paying/federal-programs |
13 |
1 |
92% |
0% |
0% |
| About-cancer/treatment/clinical-trials/paying/insurance |
19 |
1 |
94% |
0% |
0% |
| About-cancer/treatment/clinical-trials/paying/work-with-insurance |
21 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/clinical-trials/questions |
39 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/clinical-trials/search/help |
118 |
1 |
99% |
0% |
0% |
| About-cancer/treatment/clinical-trials/search/trial-guide |
74 |
74 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/taking-part |
26 |
26 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials |
20 |
20 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/phases |
21 |
21 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/placebo |
4 |
4 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/randomization |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/team |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/types |
38 |
38 |
0% |
0% |
0% |
| About-cancer/treatment/clinical-trials/what-are-trials/where |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/drugs |
590 |
590 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/access-experimental |
43 |
43 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/amifostine |
26 |
26 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/aminolevulinicacid |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/anal |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/aprepitant |
26 |
26 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/asparaginase-erwinia-chrysanthemi |
22 |
22 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/bexarotene |
27 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/bladder |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/bleomycin |
30 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/bone |
11 |
1 |
90% |
0% |
0% |
| About-cancer/treatment/drugs/brain |
18 |
1 |
94% |
0% |
0% |
| About-cancer/treatment/drugs/breast |
85 |
2 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/cancer-type |
44 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/caplacizumab-yhdp |
16 |
1 |
93% |
0% |
0% |
| About-cancer/treatment/drugs/cervical |
22 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/colorectal |
89 |
1 |
98% |
0% |
0% |
| About-cancer/treatment/drugs/darbepoetinalfa |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/defibrotide-sodium |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/denosumab |
39 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/dexamethasone |
37 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/dexamethasonel |
37 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/dexrazoxanehydrochloride |
26 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/eltrombopagolamine |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/emapalumab-lzsg |
25 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/endometrial |
9 |
1 |
88% |
0% |
0% |
| About-cancer/treatment/drugs/epoetinalfa |
27 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/esophageal |
20 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/everolimus |
35 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/filgrastim |
34 |
1 |
97% |
0% |
0% |
| About-cancer/treatment/drugs/fostamatinibdisodium |
25 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/gestationaldisease |
9 |
1 |
88% |
0% |
0% |
| About-cancer/treatment/drugs/gist |
10 |
1 |
90% |
0% |
0% |
| About-cancer/treatment/drugs/glucarpidase |
24 |
1 |
95% |
0% |
0% |
| About-cancer/treatment/drugs/granisetron |
26 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/granisetronhydrochloride |
26 |
1 |
96% |
0% |
0% |
| About-cancer/treatment/drugs/head-neck |
19 |
1 |
94% |
0% |
0% |
| About-cancer/treatment/drugs/imatinibmesylate |
33 |
33 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/imiquimod |
27 |
26 |
3% |
0% |
0% |
| About-cancer/treatment/drugs/kaposi-sarcoma |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/kidney |
36 |
36 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/lanreotideacetate |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/lenalidomide |
35 |
35 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/leukemia |
149 |
1 |
99% |
0% |
0% |
| About-cancer/treatment/drugs/liver |
18 |
18 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/lung |
91 |
91 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/melanoma |
34 |
34 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/mesna |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/mesothelioma |
7 |
7 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/methylnaltrexonebromide |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/midostaurin |
29 |
29 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/multicentric-castleman-disease |
6 |
6 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/multiple-myeloma |
42 |
42 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/myeloproliferative-neoplasms |
35 |
35 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/netupitant-palonosetronhydrochloride |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/neuroblastoma |
12 |
12 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/non-hodgkin |
87 |
87 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/off-label |
45 |
45 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/palonosetronhydrochloride |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/pamidronatedisodium |
28 |
28 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/pancreatic |
31 |
31 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/pegfilgrastim |
28 |
28 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/peginterferon-alfa-2b |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/penile |
6 |
6 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/pheochromocytoma-paraganglioma |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/prednisone |
35 |
35 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/prostate |
34 |
34 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/raloxifenehydrochloride |
30 |
30 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/rasburicase |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/ravulizumab-cwvz |
25 |
25 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/recombinant-hpv-nonavalent-vaccine |
37 |
37 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/recombinant-hpv-quadrivalent-vaccine |
40 |
40 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/recombinant-interferon-alfa-2b |
31 |
31 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/related-conditions |
92 |
92 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/retinoblastoma |
13 |
13 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/rhabdomyosarcoma |
7 |
7 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/rolapitanthydrochloride |
24 |
24 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/romiplostim |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/skin |
53 |
53 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/soft-tissue-sarcoma |
20 |
20 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/solid-tumors |
11 |
11 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/stomach |
33 |
33 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/talc |
26 |
26 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/testicular |
23 |
23 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/thiotepa |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/thyroid |
17 |
17 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/tocilizumab |
27 |
27 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/uridinetriacetate |
26 |
26 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/vaginal |
8 |
8 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/vulvar |
13 |
13 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/wilms-tumor |
8 |
8 |
0% |
0% |
0% |
| About-cancer/treatment/drugs/zoledronicacid |
28 |
28 |
0% |
0% |
0% |
| About-cancer/treatment/questions |
33 |
33 |
0% |
0% |
0% |
| About-cancer/treatment/questionssearch |
34 |
34 |
0% |
0% |
0% |
| About-cancer/treatment/research |
200 |
200 |
0% |
0% |
0% |
| About-cancer/treatment/side-effects |
31 |
31 |
0% |
0% |
0% |
| About-cancer/treatment/types/chemotherapy |
92 |
92 |
0% |
0% |
0% |
| About-cancer/treatment/types/hormone-therapy |
60 |
60 |
0% |
0% |
0% |
| About-cancer/treatment/types/immunotherapy |
69 |
69 |
0% |
0% |
0% |
| About-cancer/treatment/types/precision-medicine |
23 |
23 |
0% |
0% |
0% |
| About-cancer/treatment/types/radiation-therapy |
58 |
58 |
0% |
0% |
0% |
| About-cancer/treatment/types/radiation-therapy/brachytherapy |
36 |
36 |
0% |
0% |
0% |
| About-cancer/treatment/types/radiation-therapy/external-beam |
98 |
98 |
0% |
0% |
0% |
| About-cancer/treatment/types/radiation-therapy/side-effects |
51 |
51 |
0% |
0% |
0% |
| About-cancer/treatment/types/stem-cell-transplant |
52 |
52 |
0% |
0% |
0% |
| About-cancer/treatment/types/surgery |
92 |
92 |
0% |
0% |
0% |
| About-cancer/treatment/types/targeted-therapies |
48 |
48 |
0% |
0% |
0% |
| About-cancer/understanding |
5 |
1 |
80% |
0% |
0% |
| About-cancer/understanding/disparities |
23 |
23 |
0% |
0% |
0% |
| About-cancer/understanding/statistics |
17 |
17 |
0% |
0% |
0% |
| About-cancer/understanding/what-is-cancer |
75 |
75 |
0% |
0% |
0% |
| About-nci/organization/ccg/about/contact |
18 |
18 |
0% |
0% |
0% |
| About-nci/organization/ccg/cancer-genomics-overview |
22 |
22 |
0% |
0% |
0% |
| About-nci/organization/ccg/funding |
20 |
20 |
0% |
0% |
0% |
| About-nci/organization/ccg/research/computational-genomics |
15 |
15 |
0% |
0% |
0% |
| About-nci/organization/ccg/research/computational-genomics/gdc |
28 |
28 |
0% |
0% |
0% |
| About-nci/organization/ccg/research/functional-genomics |
20 |
20 |
0% |
0% |
0% |
| About-nci/organization/ccg/research/genomic-pipeline |
25 |
25 |
0% |
0% |
0% |
| About-nci/organization/ccg/research/structural-genomics |
44 |
44 |
0% |
0% |
0% |
| Research/areas/biology |
56 |
56 |
0% |
0% |
0% |
| Research/areas/causes |
50 |
50 |
0% |
0% |
0% |
| Research/areas/childhood |
71 |
71 |
0% |
0% |
0% |
| Research/areas/childhood/childhood-cancer-data-initiative |
19 |
19 |
0% |
0% |
0% |
| Research/areas/clinical-trials |
52 |
52 |
0% |
0% |
0% |
| Research/areas/clinical-trials/ncorp |
12 |
12 |
0% |
0% |
0% |
| Research/areas/clinical-trials/nctn |
99 |
99 |
0% |
0% |
0% |
| Research/areas/diagnosis |
43 |
43 |
0% |
0% |
0% |
| Research/areas/disparities |
46 |
46 |
0% |
0% |
0% |
| Research/areas/genomics |
46 |
46 |
0% |
0% |
0% |
| Research/areas/global-health |
45 |
45 |
0% |
0% |
0% |
| Research/areas/prevention |
47 |
47 |
0% |
0% |
0% |
| Research/areas/public-health |
53 |
53 |
0% |
0% |
0% |
| Research/areas/screening |
37 |
37 |
0% |
0% |
0% |
| Research/areas/treatment |
60 |
60 |
0% |
0% |
0% |
| Research/key-initiatives |
17 |
17 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative |
12 |
12 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel |
45 |
45 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel/members |
38 |
38 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/funding |
4 |
4 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/funding/closed |
3 |
3 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/funding/public-access-policy |
44 |
44 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/funding/upcoming |
33 |
33 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation |
18 |
18 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/adult-immunotherapy-network |
13 |
13 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/childhood-cancer-research |
10 |
10 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/data-ecosystem |
21 |
21 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/drug-resistance |
12 |
12 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/hereditary-cancers |
10 |
10 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/human-tumor-atlas |
11 |
11 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/mine-patient-data |
8 |
8 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/new-technologies |
7 |
7 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/patient-engagement |
21 |
21 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/pediatric-immunotherapy-network |
9 |
9 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/prevention-early-detection |
21 |
21 |
0% |
0% |
0% |
| Research/key-initiatives/moonshot-cancer-initiative/implementation/symptom-management |
15 |
15 |
0% |
0% |
0% |
| Research/key-initiatives/ras/about |
60 |
60 |
0% |
0% |
0% |
| Research/key-initiatives/ras/outreach |
11 |
11 |
0% |
0% |
0% |
| Research/key-initiatives/ras/outreach/collaborations |
64 |
64 |
0% |
0% |
0% |
| Research/key-initiatives/ras/outreach/events |
61 |
61 |
0% |
0% |
0% |
| Research/key-initiatives/ras/outreach/publications |
76 |
76 |
0% |
0% |
0% |
| Research/key-initiatives/ras/outreach/reference-reagents |
13 |
13 |
0% |
0% |
0% |
| Research/key-initiatives/ras/ras-central/discussion-forum |
9 |
9 |
0% |
0% |
0% |
| Research/key-initiatives/ras/ras-central/meetings-videos |
79 |
79 |
0% |
0% |
0% |
| Research/key-initiatives/ras/ras-central/tools-resources |
31 |
31 |
0% |
0% |
0% |
| Research/key-initiatives/ras/screens-assays |
7 |
7 |
0% |
0% |
0% |
| Research/key-initiatives/ras/screens-assays/drug-discovery |
31 |
31 |
0% |
0% |
0% |
| Research/key-initiatives/ras/screens-assays/imaging |
29 |
29 |
0% |
0% |
0% |
| Research/key-initiatives/ras/spokes-funding |
21 |
21 |
0% |
0% |
0% |
| Research/key-initiatives/ras/target-identification |
11 |
11 |
0% |
0% |
0% |
| Research/key-initiatives/ras/target-identification/biochemistry-biophysics |
38 |
38 |
0% |
0% |
0% |
| Research/key-initiatives/ras/target-identification/informatics |
24 |
24 |
0% |
0% |
0% |
| Research/key-initiatives/ras/target-identification/reagents |
19 |
19 |
0% |
0% |
0% |
| Research/key-initiatives/ras/target-identification/structural-biology |
30 |
30 |
0% |
0% |
0% |
| Research/nci-role |
78 |
78 |
0% |
0% |
0% |
| Research/nci-role/bioinformatics |
31 |
31 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers |
10 |
10 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/alberteinstein |
11 |
11 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/arizonacc |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/baylorduncan |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/beckmancityofhope |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/casewestern |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/cinj |
13 |
13 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/coldspringharbor |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/dartmouthnorriscotton |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/dfharvard |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/dukeci |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/emorywinship |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/foxchase |
13 |
13 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/fredhutchcrc |
28 |
28 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/georgetownlombardi |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/hopkinskimmel |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/indianasimon |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/iowaholden |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/irvingcolumbia |
12 |
12 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/jacksonlab |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/jeffersonkimmel |
24 |
24 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/kucc |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/mayoclinic |
23 |
23 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/mdanderson |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/memorialsloankettering |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/minnesotamasonic |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/mitkoch |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/moffitt |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/muschollings |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/nebraska |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/newmexicocrtc |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/northwesternlurie |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/nyuci |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ohsuknight |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/osujamesrs/find/casewestern |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/purdueccr |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/roswellpark |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/salk |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/sanfordburnham |
12 |
12 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/stanfordci |
18 |
18 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/stephenson |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/stjude |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/sylvester-miami |
20 |
20 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/tischmountsinai |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uabccc |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ucdaviscc |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uchicagoccc |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ucirvinechao |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uclajonsson |
18 |
18 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ucolorado |
18 |
18 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ucsdmoores |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ucsfhelendiller |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uhawaiicc |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/ukmarkey |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/umdgreenebaum |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/umichiganccc |
12 |
12 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/unclineberger |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/upci |
13 |
13 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/upennabramson |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uscnorris |
18 |
18 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/utahhuntsman |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/utsanantonio |
19 |
19 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/utswsimmons |
24 |
24 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uvacc |
16 |
16 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/uwcarbone |
24 |
24 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/vanderbiltingram |
29 |
29 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/vcumassey |
18 |
18 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/wakeforest |
14 |
14 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/washingtonsiteman |
17 |
17 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/waynestatekarmanos |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/wistar |
22 |
22 |
0% |
0% |
0% |
| Research/nci-role/cancer-centers/find/yalecc |
15 |
15 |
0% |
0% |
0% |
| Research/nci-role/extramural |
26 |
26 |
0% |
0% |
0% |
| Research/nci-role/fnlcr |
12 |
12 |
0% |
0% |
0% |
| Research/nci-role/intramural |
23 |
23 |
0% |
0% |
0% |
| Research/nci-role/partners-collaborators |
38 |
38 |
0% |
0% |
0% |
| Research/nci-role/spotlight |
8 |
8 |
0% |
0% |
0% |
| Research/nci-role/spotlight/oia |
32 |
32 |
0% |
0% |
0% |
| Research/nci-role/spotlight/oia/2015 |
46 |
46 |
0% |
0% |
0% |
| Research/nci-role/spotlight/oia/2016 |
30 |
30 |
0% |
0% |
0% |
| Research/nci-role/spotlight/oia/2017 |
21 |
21 |
0% |
0% |
0% |
| Research/nci-role/spotlight/profiles |
17 |
17 |
0% |
0% |
0% |
| Research/progress/250-years-milestones |
104 |
104 |
0% |
0% |
0% |
| Research/progress/annual-report-nation |
11 |
11 |
0% |
0% |
0% |
| Research/progress/discovery |
47 |
47 |
0% |
0% |
0% |
| Treatment/drugs/dexrazoxanehydrochloride |
26 |
26 |
0% |
0% |
0% |
| Treatment/drugs/mechlorethaminehydrochloride |
31 |
31 |
0% |
0% |
0% |
| Types/adrenocortical |
6 |
1 |
83% |
0% |
0% |
| Types/anal |
7 |
1 |
85% |
0% |
0% |
| Types/aya |
70 |
25 |
64% |
0% |
0% |
| Types/bladder |
6 |
1 |
83% |
0% |
0% |
| Types/bladder/hp/bladder-screening-pdq |
17 |
17 |
0% |
0% |
0% |
| Types/bladder/patient/bladder-screening-pdq |
74 |
74 |
0% |
0% |
0% |
| Types/bladder/patient/bladder-treatment-pdq |
239 |
239 |
0% |
0% |
0% |
| Types/bladder/research |
29 |
29 |
0% |
0% |
0% |
| Types/bone |
12 |
1 |
91% |
0% |
0% |
| Types/brain |
19 |
2 |
89% |
0% |
0% |
| Types/breast |
9 |
1 |
88% |
0% |
0% |
| Types/cardiac/patient-child-cardiac-treatment-pdq |
173 |
173 |
0% |
0% |
0% |
| Types/cervical |
11 |
2 |
81% |
0% |
10% |
| Types/childhood-cancers |
44 |
44 |
0% |
0% |
0% |
| Types/childhood-cancers/late-effects-pdq |
1,116 |
943 |
15% |
0% |
0% |
| Types/childhood-cancers/patient/unusual-cancers-childhood-pdq |
989 |
5 |
99% |
0% |
0% |
| Types/colorectal |
10 |
1 |
90% |
0% |
0% |
| Types/common-cancers |
22 |
22 |
0% |
0% |
0% |
| Types/esophageal |
10 |
1 |
90% |
0% |
0% |
| Types/extracranial-germ-cell |
9 |
1 |
88% |
0% |
0% |
| Types/extragonadal-germ-cell |
9 |
1 |
88% |
0% |
0% |
| Types/eye |
10 |
1 |
90% |
0% |
0% |
| Types/gallbladder |
5 |
1 |
80% |
0% |
0% |
| Types/gestational-trophoblastic |
8 |
1 |
87% |
0% |
0% |
| Types/gi-carcinoid-tumors |
7 |
1 |
85% |
0% |
0% |
| Types/head-and-neck |
17 |
1 |
94% |
0% |
0% |
| Types/kidney |
12 |
1 |
91% |
0% |
0% |
| Types/langerhans |
4 |
1 |
75% |
0% |
0% |
| Types/leukemia |
6 |
1 |
83% |
0% |
0% |
| Types/leukemia/clinical-trials |
4 |
1 |
75% |
0% |
0% |
| Types/leukemia/patient/adult-all-treatment-pdq |
206 |
1 |
99% |
0% |
0% |
| Types/leukemia/patient/adult-aml-treatment-pdq |
191 |
1 |
99% |
0% |
0% |
| Types/leukemia/patient/child-all-treatment-pdq |
288 |
1 |
99% |
0% |
0% |
| Types/leukemia/patient/child-aml-treatment-pdq |
347 |
3 |
99% |
0% |
0% |
| Types/leukemia/patient/cll-treatment-pdq |
189 |
1 |
99% |
0% |
0% |
| Types/leukemia/patient/cml-treatment-pdq |
193 |
1 |
99% |
0% |
0% |
| Types/leukemia/patient/hairy-cell-treatment-pdq |
159 |
1 |
99% |
0% |
0% |
| Types/liver |
10 |
1 |
90% |
0% |
0% |
| Types/lung |
12 |
1 |
91% |
0% |
0% |
| Types/lymphoma |
14 |
1 |
92% |
0% |
0% |
| Types/mesothelioma |
9 |
1 |
88% |
0% |
0% |
| Types/metastatic-cancer |
34 |
34 |
0% |
0% |
0% |
| Types/midline/patient-child-midline-tract-carcinoma-treatment-pdq |
131 |
131 |
0% |
0% |
0% |
| Types/myeloma |
8 |
1 |
87% |
0% |
0% |
| Types/myeloproliferative |
16 |
1 |
93% |
0% |
0% |
| Types/neuroblastoma |
9 |
1 |
88% |
0% |
0% |
| Types/ovarian |
13 |
1 |
92% |
0% |
0% |
| Types/pancreatic |
10 |
2 |
80% |
0% |
10% |
| Types/parathyroid |
6 |
1 |
83% |
0% |
0% |
| Types/penile |
7 |
1 |
85% |
0% |
0% |
| Types/pheochromocytoma |
6 |
1 |
83% |
0% |
0% |
| Types/pituitary |
6 |
1 |
83% |
0% |
0% |
| Types/prostate |
11 |
1 |
90% |
0% |
0% |
| Types/recurrent-cancer |
20 |
20 |
0% |
0% |
0% |
| Types/retinoblastoma |
10 |
1 |
90% |
0% |
0% |
| Types/skin |
14 |
1 |
92% |
0% |
0% |
| Types/small-intestine |
4 |
1 |
75% |
0% |
0% |
| Types/soft-tissue-sarcoma |
18 |
1 |
94% |
0% |
0% |
| Types/soft-tissue-sarcoma/hp |
18 |
1 |
94% |
0% |
0% |
| Types/stomach |
9 |
1 |
88% |
0% |
0% |
| Types/testicular |
10 |
3 |
70% |
0% |
20% |
| Types/thymoma |
7 |
1 |
85% |
0% |
0% |
| Types/thyroid |
9 |
1 |
88% |
0% |
0% |
| Types/unknown-primary |
9 |
1 |
88% |
0% |
0% |
| Types/urethral |
4 |
1 |
75% |
0% |
0% |
| Types/uterine |
11 |
1 |
90% |
0% |
0% |
| Types/vaginal |
8 |
1 |
87% |
0% |
0% |
| Types/vulvar |
7 |
1 |
85% |
0% |
0% |
